gp96 autologous tumor-derived heat shock protein vaccine

heat shock protein gp96 vaccine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for gp96 autologous tumor-derived heat shock protein vaccine, covering 2016-06-06 to 2016-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96 [Phase 1, Phase 2]

See pricing